Research location
Melrose Park
Pennsylvania, United States
Advertisement
Research activity in Melrose Park
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Melrose Park
19 linked trials · page 1 of 1Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung CancerNCT02642939 · 2015-12-01 · 1 site observation
TERMINATED
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminNCT01388361 · 2011-09-01 · 1 site observation
COMPLETED
Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes MellitusNCT01364428 · 2011-06-01 · 1 site observation
COMPLETED
Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes MellitusNCT01326026 · 2011-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentNCT01164501 · 2010-07-01 · 1 site observation
COMPLETED
Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)NCT01135992 · 2010-06-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesNCT01068665 · 2010-03-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesNCT00972283 · 2009-09-01 · 1 site observation
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesNCT00839527 · 2009-02-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Albiglutide in Type 2 DiabetesNCT00849017 · 2009-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide in Type 2 DiabetesNCT00849056 · 2009-01-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.NCT00744367 · 2008-10-01 · 1 site observation
COMPLETED
Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation
COMPLETED
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)NCT00549757 · 2007-10-01 · 1 site observation
TERMINATED
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes MellitusNCT00418522 · 2007-03-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00097877 · 2005-01-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesNCT00097279 · 2004-08-01 · 1 site observation
COMPLETED
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 DiabeticsNCT00240370 · 2003-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.